Literature DB >> 7544326

Changes of acute phase proteins glycosylation profile as a possible prognostic marker in myocardial infarction.

M Kaźmierczak1, M Sobieska, K Wiktorowicz, H Wysocki.   

Abstract

In 24 consecutive patients with myocardial infarction, the concentrations of C-reactive protein, alpha 1-acid glycoprotein and alpha 1-antichymotrypsin, as well as acid alpha 1-glycoprotein and alpha 1-antichymotrypsin glycosylation profiles were estimated. Blood samples were taken at admission, after 4, 8, 12 and 24 h, on 2, 3, 6, 9, and 12 days of hospitalization. All studied patients were divided into 2 groups: 12 patients without clinical or radiological symptoms of acute heart failure and 12 patients with acute heart failure. The results of all investigations were tested statistically to appraise significance of differences between the two investigated groups. At admission, as well as after 6 and 12 h, C-reactive protein concentration was significantly higher in patients who developed heart failure. Similarly, the glycosylation profile of alpha 1-antichymotrypsin, reported as reactivity coefficient, was of good prognostic value from the first time-point on. Development of acute cardiac failure seemed to correlate more with the magnitude of inflammatory reaction (measured by changes in acute phase proteins) than with enzymatically estimated infarct size.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544326     DOI: 10.1016/0167-5273(95)02322-n

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Systemic inflammation in cardiovascular and periodontal disease: comparative study.

Authors:  Ingrid Glurich; Sara Grossi; Boris Albini; Alex Ho; Rashesh Shah; Mohamed Zeid; Heinz Baumann; Robert J Genco; Ernesto De Nardin
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction.

Authors:  Natale Daniele Brunetti; Pier Luigi Pellegrino; Michele Correale; Luisa De Gennaro; Andrea Cuculo; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2007-11-24       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.